Freedom of Information request on the data from MHRA database on the number of Yellow Cards reported and the names of medications reported on the Yellow Cards from Northampton General Hospital in the last 2 years ( FOI 21/1125)
Published 26 May 2022
© Crown copyright 2022
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/freedom-of-information-responses-from-the-mhra-week-commencing-1-november-2021/freedom-of-information-request-on-the-data-from-mhra-database-on-the-number-of-yellow-cards-reported-and-the-names-of-medications-reported-on-the-yell
FOI 21/1125
1st November 2021
Dear,
Thank you for your email dated 11th October, where you asked for information on the following:
Data from MHRA database on the number of Yellow Cards reported and the names of medications reported on the Yellow Cards from Northampton General Hospital in the last 2 years.
Further to your request, during the period of 20th October 2019 to 20th October 2021 we have received a total of 169 suspected spontaneous UK Yellow Card reports from Northampton General Hospital. Please find attached Table 1, which lists the name of the suspect drugs reported within these Yellow Card reports and how many reports we have received for each substance.
Please note that the database used to capture information from Yellow Cards is dynamic and therefore numbers are subject to change over time. It is also important to bear in mind the following points when interpreting Yellow Card data:
• This information should only be used for education and promotion and should not be used for audit purposes.
• Please be aware, the reporting of a particular reaction does not necessarily mean that it has been caused by a drug or vaccine. Many factors must be considered in assessing the relationship between a drug or vaccine and suspected reaction including the possible contribution of other drugs being taken, and the underlying disease.
• The number of reports received should not be used as a basis for determining incidence of a reaction as neither the total number of reactions occurring, nor the number of patients using a drug or vaccine is included in this data.
I hope the information provided is helpful, but if you are dissatisfied with the handling of your request, you have the right to ask for an internal review. Internal review requests should be submitted within two months of the date of this response; and can be addressed to this email address.
Yours sincerely,
FOI Team,
Vigilance and Risk Management of Medicines Division